Indivior Pharmaceuticals, Inc.

1. 01

   Above its 50- and 200-day averages

   The 2 Nov 2026 close of $36.28 was 3.1% above its 50-day average ($35.18) and 1.7% above its 200-day average ($35.68). It has closed above the 200-day for 1 session, since 2 Nov 2026. The 50-day average crossed below the 200-day on 22 Oct 2026, 7 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 2 Nov 2026

2. 02

   Ahead of SPY, behind its sector fund XLV over 1 year

   1 month: +1.6% (SPY −2.3%, XLV +11.1%). 3 months: −2.9% (SPY −0.7%, XLV +13.8%). 1 year: +23.5% (SPY +10.3%, XLV +28.0%). Price change to the 2 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: INDV, SPY and XLV · as of 2 Nov 2026

3. 03

   Volume 2.0× its 30-session average on 2 Nov 2026

   2 Nov 2026 volume of 4.9M shares was 2.0× the average of the 30 sessions before it (2.4M), as the price rose 2.6%. SPY traded 1.2× its own average that session.

   Daily volume against a 30-session baseline · as of 2 Nov 2026

4. 04

   57% of the way up its 52-week range

   Closed at $36.28 on 2 Nov 2026: 15.3% below the 52-week high of $42.81 (26 Jun 2026) and 31.1% above the low of $27.68 (24 Mar 2026).

   Daily price bars, split-adjusted · as of 2 Nov 2026

5. 05

   9.4M shares sold short

   9.4M shares were sold short at the 15 Oct 2026 settlement; covering them would take 3.4 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 2 Nov 2026 close